VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2017 | Interferons: a promising potential therapy for MPN

Ruben Mesa, MD, FACP, from the Mayo Cancer Clinic Center, Rochester, MN, USA, provides us an insight into the potential of treating patients with myeloproliferative neoplasms (MPN) with interferons. Here, he discusses the PROUD-PV study (NCT01949805), a Phase III trial comparing the efficacy and safety of the novel interferon AOP2014 against hydroxyurea in treating polycythemia vera, and notes that there may be selectivity in the interferon for clones of MPN. This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter